Cases 91 - 100 of 144
MITSUBISHI TANABE PHARMA CORPORATION et al v. MSN LABORATORIES PRIVATE LTD. et al
as 3:2017cv05302
Plaintiff:
MITSUBISHI TANABE PHARMA CORPORATION , JANSSEN PHARMACEUTICALS, INC. , JANSSEN PHARMACEUTICA NV and others
Defendant:
MSN LABORATORIES PRIVATE LTD., MSN PHARMACEUTICALS, INC., LAURUS LABS LTD. and others
Cause Of Action: 15 U.S.C. § 1126
MITSUBISHI TANABE PHARMA CORPORATION et al v. SANDOZ INC. et al
as 3:2017cv05319
Plaintiff:
MITSUBISHI TANABE PHARMA CORPORATION , JANSSEN PHARMACEUTICALS, INC. , JANSSEN PHARMACEUTICA NV and others
Defendant:
SANDOZ INC. and ZYDUS PHARMACEUTICALS (USA) INC.
Counter_claimant:
ZYDUS PHARMACEUTICALS (USA) INC.
Counter_defendant:
CILAG GMBH INTERNATIONAL , JANSSEN PHARMACEUTICA NV , JANSSEN PHARMACEUTICALS, INC. and others
Cause Of Action: 15 U.S.C. § 1126
MITSUBISHI TANABE PHARMA CORP. et al v. APOTEX, INC., et al
as 3:2017cv05278
Plaintiff:
MITSUBISHI TANABE PHARMA CORPORATION , JANSSEN PHARMACEUTICALS, INC. , JANSSEN PHARMACEUTICA NV and others
Defendant:
APOTEX, INC. and APOTEX CORP.
Cause Of Action: 15 U.S.C. § 1126
MITSUBISHI TANABE PHARMA CORPORATION et al v. PRINSTON PHARMACEUTICAL, INC. et al
as 3:2017cv05135
Plaintiff:
MITSUBISHI TANABE PHARMA CORPORATION , JANSSEN PHARMACEUTICALS, INC. , JANSSEN PHARMACEUTICA NV and others
Defendant:
PRINSTON PHARMACEUTICAL, INC., DR. REDDY'S LABORATORIES, INC., DR. REDDY'S LABORATORIES, LTD. and others
Cause Of Action: 15 U.S.C. § 1126
MITSUBISHI TANABE PHARMA CORPORATION et al v. AUROBINDO PHARMA USA, INC. et al
as 3:2017cv05005
Plaintiff:
MITSUBISHI TANABE PHARMA CORPORATION , JANSSEN PHARMACEUTICALS, INC. , JANSSEN PHARMACEUTICA NV and others
Defendant:
AUROBINDO PHARMA USA, INC., INVAGEN PHARMACEUTICALS, INC., MACLEODS PHARMACEUTICALS, LTD. and others
Cause Of Action: 15 U.S.C. § 1126
Bayer Intellectual Property GMBH et al v. InvaGen Pharmaceuticals, Inc.
as 1:2017cv00812
Plaintiff:
Bayer Intellectual Property GMBH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
InvaGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GmbH et al v. Alembic Pharmaceuticals Limited et al
as 1:2017cv00675
Plaintiff:
Bayer Intellectual Property GmbH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Alembic Pharmaceuticals Limited, Alembic Global Holding SA and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GmbH et al v. Sigmapharm Laboratories, LLC
as 1:2017cv00648
Plaintiff:
Bayer Intellectual Property GmbH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Sigmapharm Laboratories, LLC
Counter_claimant:
Sigmapharm Laboratories, LLC
Counter_defendant:
Bayer AG , Bayer Intellectual Property GmbH and Janssen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GmbH et al v. Mylan Pharmaceuticals Inc.
as 1:2017cv00584
Plaintiff:
Bayer Intellectual Property GmbH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GmbH et al v. Micro Labs Ltd. et al
as 1:2017cv00560
Plaintiff:
Bayer Intellectual Property GmbH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Micro Labs Ltd. and Micro Labs USA Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
